JP2016519138A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519138A5 JP2016519138A5 JP2016512345A JP2016512345A JP2016519138A5 JP 2016519138 A5 JP2016519138 A5 JP 2016519138A5 JP 2016512345 A JP2016512345 A JP 2016512345A JP 2016512345 A JP2016512345 A JP 2016512345A JP 2016519138 A5 JP2016519138 A5 JP 2016519138A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- protein
- tafa4
- seq
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305592.1 | 2013-05-06 | ||
| EP13305592.1A EP2801369A1 (en) | 2013-05-06 | 2013-05-06 | TAFA4 compounds and uses thereof for treating pain |
| PCT/EP2014/059247 WO2014180853A1 (en) | 2013-05-06 | 2014-05-06 | Tafa4 compounds and uses thereof for treating pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519138A JP2016519138A (ja) | 2016-06-30 |
| JP2016519138A5 true JP2016519138A5 (enExample) | 2018-08-30 |
| JP6487419B2 JP6487419B2 (ja) | 2019-03-20 |
Family
ID=48428409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016512345A Active JP6487419B2 (ja) | 2013-05-06 | 2014-05-06 | Ｔａｆａ４化合物及び疼痛を処置するためのその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9884088B2 (enExample) |
| EP (2) | EP2801369A1 (enExample) |
| JP (1) | JP6487419B2 (enExample) |
| CN (1) | CN105209056B (enExample) |
| CA (2) | CA2910652C (enExample) |
| DK (1) | DK2994157T3 (enExample) |
| ES (1) | ES2813629T3 (enExample) |
| WO (1) | WO2014180853A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3270160B1 (en) * | 2015-03-13 | 2020-03-18 | Sysmex Corporation | Method for detecting test substance and reagent kit used in said method |
| JP2021501334A (ja) * | 2017-10-30 | 2021-01-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 電気化学的センサーを用いた、分析物の較正不要なインビボ測定 |
| AU2019259798A1 (en) * | 2018-04-24 | 2020-11-12 | Neuracle Science Co., Ltd. | Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of neuropathic pain |
| WO2020064907A1 (en) * | 2018-09-27 | 2020-04-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical composition reducing skin inflammation |
| CN109596818B (zh) * | 2018-12-13 | 2024-03-19 | 丁蓉 | 一种基于电生理学分析当归四逆汤预防奥沙利铂神经毒性机制的研究方法 |
| KR20220137009A (ko) * | 2020-02-04 | 2022-10-11 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 염증 질환을 치료하기 위한 방법 및 약제학적 조성물 |
| KR20230010622A (ko) * | 2020-02-13 | 2023-01-19 | 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 | Piez02-매개 통증을 감소시키는 마가르산 |
| TWI759788B (zh) * | 2020-07-08 | 2022-04-01 | 台灣粒線體應用技術股份有限公司 | 萃取保護液用於自細胞分離粒線體並維持粒線體活性的用途 |
| JP2024547029A (ja) | 2021-12-17 | 2024-12-26 | タファルジー・セラピューティクス | 疼痛の処置における使用のためのペプチド及び方法 |
| CA3242979A1 (en) * | 2021-12-20 | 2023-06-29 | Amgen Inc. | DLL3 LINKING PEPTIDES AND THEIR USES |
| US20230302207A1 (en) * | 2022-03-24 | 2023-09-28 | Baxter International Inc. | Dialysis system having thermoelectric heating |
| AR129441A1 (es) | 2022-05-25 | 2024-08-28 | Tafalgie Therapeutics | Péptidos y métodos para el tratamiento del dolor |
| US20260041790A1 (en) * | 2022-05-31 | 2026-02-12 | Neuracle Genetics Inc. | Composition for treating retinal or macular diseases |
| KR20250153765A (ko) | 2023-02-17 | 2025-10-27 | 나오스 인스티튜트 오브 라이프 사이언스 | 피부 내성 역치를 증가시킬 수 있는 생태생물학적 화합물의 선택 방법 |
| WO2025116606A1 (ko) * | 2023-11-30 | 2025-06-05 | 주식회사 뉴라클제네틱스 | 신규한 케모카인-유사 단백질 단편 |
| CN121249875B (zh) * | 2025-10-13 | 2026-03-20 | 上海交通大学医学院附属仁济医院 | 外周神经系统中的Mas相关G蛋白耦联受体D在缓解阿片类药物耐受中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090077680A1 (en) * | 2000-06-12 | 2009-03-19 | Alejandro Abuin | Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same |
| US20090136552A1 (en) * | 2004-07-30 | 2009-05-28 | Mette Gronborg | Growth factors nsg28, nsg30, and nsg32 |
-
2013
- 2013-05-06 EP EP13305592.1A patent/EP2801369A1/en not_active Withdrawn
-
2014
- 2014-05-06 WO PCT/EP2014/059247 patent/WO2014180853A1/en not_active Ceased
- 2014-05-06 CA CA2910652A patent/CA2910652C/en active Active
- 2014-05-06 ES ES14723045T patent/ES2813629T3/es active Active
- 2014-05-06 EP EP14723045.2A patent/EP2994157B1/en active Active
- 2014-05-06 DK DK14723045.2T patent/DK2994157T3/da active
- 2014-05-06 CA CA3235916A patent/CA3235916A1/en active Pending
- 2014-05-06 US US14/787,483 patent/US9884088B2/en active Active
- 2014-05-06 JP JP2016512345A patent/JP6487419B2/ja active Active
- 2014-05-06 CN CN201480025716.5A patent/CN105209056B/zh active Active
-
2017
- 2017-12-14 US US15/841,342 patent/US20180110829A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7379428B2 (ja) | Ｎｋ細胞におけるサイトカイン誘導性ｓｈ２タンパク質の阻害 | |
| EP3371207B1 (en) | Nucleic acids, peptides and methods | |
| Baker et al. | An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders | |
| Park et al. | Molecular cloning and functional analysis of nucleotide-binding oligomerization domain 1 (NOD1) in olive flounder, Paralichthys olivaceus | |
| Rothenburg et al. | Double-stranded RNA-activated protein kinase PKR of fishes and amphibians: varying the number of double-stranded RNA binding domains and lineage-specific duplications | |
| US20160025745A1 (en) | Methods of diagnosing and treating fibrosis | |
| JP2019500414A5 (enExample) | ||
| JP2017213006A5 (enExample) | ||
| JP2015522264A5 (enExample) | ||
| CN105209056A (zh) | Tafa4化合物及其用于治疗疼痛的用途 | |
| US11931402B2 (en) | Compositions for treating heart disease by inhibiting the action of mAKAP-β | |
| WO2019144053A1 (en) | Gdf11 variants and uses thereof | |
| JP2017533910A5 (enExample) | ||
| Hu et al. | Interferon regulatory factor 3 (IRF-3) in Japanese flounder, Paralichthys olivaceus: sequencing, limited tissue distribution, inducible expression and induction of fish type I interferon promoter | |
| US20250250631A1 (en) | Kelch Domain Containing 7B (KLHDC7B) Variants And Uses Thereof | |
| WO2019010301A1 (en) | TREATMENT OF CARDIOPATHIES BY INHIBITING THE ACTION OF PROTEINS FROM ANCHORING TO MUSCLE PROTEIN KINASES A (MAKAP) | |
| US20100266579A1 (en) | Treatment of inflammatory diseases | |
| US20060154886A1 (en) | Regulatory elements in the 5' region of the VR1 gene | |
| JP5793188B2 (ja) | 自己免疫疾患治療及び予防薬としてのｃｔｒｐ６ | |
| Xiao et al. | Cloning of common carp SOCS-3 gene and its expression during embryogenesis, GH-transgene and viral infection | |
| Oliveira Filho et al. | Cloning, sequencing and expression analysis of the equine hepcidin gene by real-time PCR | |
| Atianand et al. | Recent evolution of the NF-κB and inflammasome regulating protein POP2 in primates | |
| CN112153897B (zh) | 用于治疗神经病学和其他病症的组合物和方法 | |
| DK2536747T3 (en) | POLYNUCLEOTIDE USED FOR THE TREATMENT OF INFLUENZA A VIRUS-INDUCED DISEASES AND CODING MODIFIED MX PROTEIN, THE MODIFIED MODIFIED MX PROTEIN, AND A TRANSGENT ANIMATED DRIVE, AS AN EXTENDED ANIMALS, AS AN EXTERNAL DRIVE, AS AN EXTENDED ANIMALS | |
| EP4305167A1 (en) | Immune enhancers |